Treatment for hypertension, male in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
Middle East, North Africa, Afghanistan & Pakistan (excluding high income): Treatment for hypertension, male was 31.1% in 2019. ▲ Rising
Treatment for hypertension, male in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), 1990–2019
Source: World Health Organization's Global Health Observatory Data Repository. Measured in % of male adults ages 30-79 with hypertension.
Analysis
In 2019, treatment for hypertension, male in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) stood at 31.1%. That is the highest value across all 30 years on record.
That represents a change of up 0.5% on the previous year and up 13.8% over ten years.
Over the whole period, treatment for hypertension, male in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) peaked at 31.1% in 2019 and was at its lowest, 15.0%, in 1990.
That places Middle East, North Africa, Afghanistan & Pakistan (excluding high income) 28th out of 43 groups with data for 2019, putting it in the middle of the range.
The long-run direction has been consistently rising across the 30 years of available data.
Treatment for hypertension, male in Middle East, North Africa, Afghanistan & Pakistan (excluding high income), year by year
| Year | % of male adults ages 30-79 with hypertension | Change |
|---|---|---|
| 1990 | 15.0% | — |
| 1991 | 15.4% | +2.6% |
| 1992 | 15.8% | +2.8% |
| 1993 | 16.3% | +2.9% |
| 1994 | 16.8% | +3.0% |
| 1995 | 17.3% | +3.0% |
| 1996 | 17.8% | +3.2% |
| 1997 | 18.4% | +3.2% |
| 1998 | 19.0% | +3.1% |
| 1999 | 19.6% | +3.4% |
| 2000 | 20.3% | +3.6% |
| 2001 | 21.0% | +3.5% |
| 2002 | 21.8% | +3.8% |
| 2003 | 22.6% | +3.6% |
| 2004 | 23.5% | +3.8% |
| 2005 | 24.3% | +3.5% |
| 2006 | 25.1% | +3.4% |
| 2007 | 25.9% | +3.0% |
| 2008 | 26.6% | +2.9% |
| 2009 | 27.3% | +2.6% |
| 2010 | 27.9% | +2.3% |
| 2011 | 28.5% | +2.1% |
| 2012 | 29.0% | +1.8% |
| 2013 | 29.5% | +1.6% |
| 2014 | 29.9% | +1.4% |
| 2015 | 30.2% | +1.1% |
| 2016 | 30.6% | +1.0% |
| 2017 | 30.7% | +0.6% |
| 2018 | 30.9% | +0.6% |
| 2019 | 31.1% | +0.5% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 1990s | 17.1% | 15.0% | 19.6% | 10 |
| 2000s | 23.8% | 20.3% | 27.3% | 10 |
| 2010s | 29.8% | 27.9% | 31.1% | 10 |
Countries ranked near Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
More health data for Middle East, North Africa, Afghanistan & Pakistan (excluding high income)
- Population ages 35-39, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, male, annual growth rate 3.11 % change on previous year (2025)
- Population ages 40-44, female, per capita 0.0305 units per person (2025)
- Population ages 40-44, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 40-44, female, annual growth rate 3.21 % change on previous year (2025)
- Population ages 35-39, male, per capita 0.0351 units per person (2025)
- Population ages 35-39, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 35-39, male, annual growth rate 1.51 % change on previous year (2025)
- Population ages 35-39, female, per capita 0.0341 units per person (2025)
- Population ages 30-34, female, annual growth rate 0.4849 % change on previous year (2025)
All data for Middle East, North Africa, Afghanistan & Pakistan (excluding high income) →
Frequently asked questions
- What is treatment for hypertension, male in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- Treatment for hypertension, male in Middle East, North Africa, Afghanistan & Pakistan (excluding high income) was 31.1% in 2019, according to World Health Organization's Global Health Observatory Data Repository.
- What is the highest treatment for hypertension, male recorded in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- The highest recorded value was 31.1% in 2019.
- What is the lowest treatment for hypertension, male recorded in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- The lowest recorded value was 15.0% in 1990.
- How does Middle East, North Africa, Afghanistan & Pakistan (excluding high income) rank for treatment for hypertension, male?
- Middle East, North Africa, Afghanistan & Pakistan (excluding high income) ranks 28th out of 43 groups with data for 2019.
- Is treatment for hypertension, male rising or falling in Middle East, North Africa, Afghanistan & Pakistan (excluding high income)?
- Over the last ten years it is up 13.8%. The long-run trend across the full record is rising.
- Where does this Middle East, North Africa, Afghanistan & Pakistan (excluding high income) data come from?
- The figures come from World Health Organization's Global Health Observatory Data Repository, published as part of Treatment for hypertension, male (% of male adults ages 30-79 with hypertension). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 30 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Treatment for hypertension, male, is the percentage of adults ages 30-79 with hypertension who were taking medicine for hypertension. Hypertension is defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension.